Dinesh Yogaratnam to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Dinesh Yogaratnam has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.148
-
Tepede A, Yogaratnam D. Nintedanib for Idiopathic Pulmonary Fibrosis. J Pharm Pract. 2019 Apr; 32(2):199-206.
Score: 0.148
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.